Centene Corporation vs Palo Alto Networks, Inc.: Strategic Comparison

This in-depth comparison examines Centene Corporation and Palo Alto Networks, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Centene Corporation on its own, evaluating Palo Alto Networks, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Centene Corporation and Palo Alto Networks, Inc. is widest.

On the headline numbers, Centene Corporation reports annual revenue of $194.8B against $8.0B for Palo Alto Networks, Inc., while their respective market capitalizations stand at $40.0B and $118.0B. Centene Corporation is headquartered in United States and Palo Alto Networks, Inc. operates from United States, and those different home markets shape how each company competes.

Centene Corporation: Centene purchases healthcare services from providers on negotiated rates, while simultaneously collecting capitated premiums from state and federal governments on a per-member-per-month (PMPM) basis. The revenue streams are segmented into four primary operational pillars. The commercial infrastructure required to support this model is highly specialized. Centene employs a massive workforce of care managers, nurses, and social workers who engage directly with members, providing complex care coordination, social determinant of health interventions, and chronic disease management rather than simple claims processing. Unlike traditional medical claims that can be processed in massive batches and stored in digital warehouses for years, behavioral health interventions require a highly complex, human-centric care coordination system that involves the continuous monitoring of member progress from the initial assessment to the final therapy session. In the specialty pharmacy space, the competitive pattern are far more complex. Companies like Icon plc in clinical trials and Catalent in manufacturing operate with lower overhead and higher R&D efficiency, allowing them to bring novel commercialization services to market faster than a diversified giant like Centene. This low gross margin is characteristic of the managed care industry and reflects the intense regulatory pressure from the Centers for Medicare & Medicaid Services (CMS) and state Medicaid agencies. Honestly, the physical infrastructure required to administer healthcare benefits for 26 million members is not a simple network of call centers; it requires a highly complex, CMS-compliant, data-driven care management system that can handle everything from routine preventive care to complex behavioral health interventions. In 2001, Centene merged with several smaller Medicaid administrators to form the modern entity, creating the largest provider of government-sponsored healthcare programs in the United States.

Palo Alto Networks, Inc.: By developing the App-ID, User-ID, and Content-ID engines, Palo Alto Networks decoupled security policy from network topology, allowing enterprises to identify and control applications regardless of the port, protocol, or encryption method used, a model shift that rendered legacy vendors like Cisco and Juniper obsolete in the enterprise perimeter defense market. The competitive dynamic between Palo Alto Networks and CrowdStrike is defined by a battle for the central nervous system of the enterprise security operations center (SOC); CrowdStrike approaches the SOC from the endpoint outward, using its massive endpoint telemetry to drive its XSIAM and Cortex XDR offerings, while Palo Alto Networks approaches the SOC from the network and cloud inward, using its massive network and cloud telemetry to drive its Cortex platform. The competitive landscape is further complicated by the emergence of specialized point solutions in identity security (Okta, Ping Identity), data security (Varonis, BigID), and application security (Snyk, SonarSource), which Palo Alto Networks attempts to displace by bundling these capabilities into the unified platform, arguing that a unified data model is superior to a fragmented stack of best-of-breed tools. Finally, the macroeconomic environment has triggered a prolonged IT spending scrutiny, with enterprise CIOs extending sales cycles for large, multi-year platform deals by an average of 30 days and demanding deeper discounting to justify the upfront capital expenditure required to rip and replace legacy security vendors. This deep packet inspection and application-layer visibility allows Palo Alto Networks to enforce zero-trust security policies based on the actual identity of the user, the specific application being used, and the exact content being transferred, regardless of the port, protocol, or encryption method, a capability that is fundamentally required for securing complex, multi-cloud enterprise networks and is impossible to achieve solely from the endpoint. The fourth pillar is the platformization architecture itself; by consolidating network security, cloud security, endpoint security, and security operations into a single codebase and a single data lake, Palo Alto Networks eliminates the data silos and integration friction that plague customers who assemble their security stack from disparate point solutions. Palo Alto Networks was conceived in the mind of Nir Zuk in 2004, while he was serving as a distinguished engineer and core developer at Check Point Software Technologies, the early mover of the stateful inspection firewall. The founding philosophy was simple but heretical at the time: security must be applied at the application layer, not the network layer, and it must be done without degrading network performance. In 2007, Palo Alto Networks emerged from stealth with the PA-100 and PA-200 series firewalls, products that were fundamentally different from anything on the market: they could identify and control applications like Skype, BitTorrent, and Facebook, regardless of the port they used, and they could do so at line speed without dropping packets or introducing latency.

Centene Corporation and Palo Alto Networks, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Centene Corporation and Palo Alto Networks, Inc..

Centene Corporation business model: The pricing power inherent in the managed care model is heavily distorted by the immense negotiating use of the government payers. In the US Medicaid distribution space, the company is currently fighting a defensive war to maintain the dominance of its state contracts against the aggressive pricing tactics of UnitedHealth Group and Elevance Health, and the immense negotiating use of consolidated retail chains like CVS Health and Walgreens Boots Alliance. The competitive narrative in the 340B drug pricing program is equally pattern, with the rapid emergence of contract pharmacy arrangements and aggressive manufacturer audit practices threatening to displace legacy hospital distribution contracts. Honestly, this strategy of identifying unmet operational needs in complex, highly regulated healthcare markets and developing targeted supply chain solutions to address them is a core component of Centene's competitive strategy, allowing the company to command premium service fees and achieve higher margins despite the intense competitive pressure in the broader pharmaceutical distribution market. The company's deep integration with pharmaceutical manufacturers through its commercialization services network creates a feedback loop of real-world data that accelerates regulatory approvals and label expansions, further entrenching its dominance in the therapeutic area. The company must also manage the complex and evolving pricing and reimbursement landscape, particularly in the US where the consolidation of retail pharmacies and the expansion of the 340B program are expected to put significant downward pressure on distribution margins.

Palo Alto Networks, Inc. business model: The transition from perpetual hardware licenses to consumption-based and subscription-based software models — accelerated by the introduction of the Cloud-Delivered Security Services (CDSS) subscriptions and the strategic acquisitions of Bridgecrew, Aperture, and Dig — positions the company to capture the next $50 billion expansion of the total addressable market in security platform consolidation. The total revenue of $6.95 billion is divided into three primary categories: system sales (hardware firewalls and physical appliances), software licenses (perpetual and subscription-based), and subscriptions (Cloud-Delivered Security Services, Prisma Cloud, and Cortex SaaS). The subscription revenue stream is anchored by the Cloud-Delivered Security Services (CDSS) portfolio, which includes Threat Prevention, WildFire sandboxing, GlobalProtect, and DNS Security, all of which are sold as annual or multi-year per-endpoint or per-throughput subscriptions that attach directly to the firewall hardware or virtual instances. This strategy is monetized through the '8-11-3' consolidation framework, which quantifies the value proposition for enterprise customers: replacing eight security point solutions, consolidating eleven security vendors, and reducing three security operations centers, thereby lowering total cost of ownership by an average of 30% while improving security efficacy. The pricing architecture for the platform is designed to capture value as the customer's digital footprint expands; as a customer adds new cloud workloads, remote users, or branch offices, the subscription fees for Prisma Cloud, Prisma Access, and GlobalProtect automatically scale, ensuring that Palo Alto Networks' revenue grows in direct proportion to the customer's attack surface expansion. The hardware segment, while financially dilutive to gross margins compared to pure software, is strategically vital for penetrating the highly regulated sectors, including government, defense, and critical infrastructure, where physical data diodes and on-premise hardware appliances are mandated by compliance frameworks, serving as a wedge to eventually migrate these highly sticky customers to the cloud-native subscription model as their IT architectures modernize. Microsoft controls the underlying operating system telemetry pipeline, allowing Defender to operate with a performance advantage that third-party agents must continuously engineer around, creating an asymmetric competitive dynamic where Palo Alto Networks must justify its Cortex endpoint licensing fees through superior cross-platform coverage and advanced threat intelligence that Microsoft cannot match. Fortinet's aggressive pricing and its secure networking bundle, which combines firewall, SD-WAN, and wireless LAN controllers into a single hardware appliance, have allowed it to capture significant market share in the branch office and remote location segments, forcing Palo Alto Networks to continuously innovate its own SD-WAN capabilities and compress its hardware margins to remain competitive. This macroeconomic headwind compresses Palo Alto Networks' average selling price (ASP) and delays the recognition of large subscription bookings, creating short-term volatility in the Next-Gen Security ARR growth rate and putting pressure on the company to continuously deliver flawless execution to meet Wall Street's elevated growth expectations. These early adopters provided the critical feedback and validation that allowed Palo Alto Networks to refine the product and establish the company as the pioneer of the next-generation firewall category, a category that would eventually render the legacy firewall market obsolete and force every major network vendor to completely rewrite their security architectures.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Centene Corporation stack up against those of Palo Alto Networks, Inc..

Centene Corporation competitive advantage: This narrative of regulatory adaptation, operational scale, and strategic reinvention defines the modern Centene, an organization that has successfully used the massive cash flows from its government contracts to build a diversified healthcare services platform capable of competing in the most complex therapeutic areas known to modern medicine. The execution of this strategy requires flawless operational execution and unprecedented regulatory compliance, capabilities that were severely tested during the rapid scale-up of ACA Marketplace enrollment and the subsequent integration of the Magellan Health network. The company's financial profile is characterized by thin operating margins of 2-4% due to federal Medical Loss Ratio (MLR) requirements, but generates massive absolute dollar profits through its scale of 26 million members. This margin structure is vastly inferior to the 10-15% margins typical of commercial insurers, but it is offset by the massive scale of the company's membership base and the predictability of government-funded premiums. This structural advantage allows the company to generate billions in absolute dollar profits despite the thin percentage margins, funding aggressive share repurchases, dividend growth, and strategic acquisitions, even as net income margins remain compressed. The premium rates for Medicaid and Medicare Advantage are set by CMS and state agencies, but the net revenue realized by Centene after risk adjustment and quality bonuses is significantly higher, representing a risk-adjustment bubble that forces the company to maintain exceptionally accurate coding practices to preserve its net revenue margins. The ultimate goal of the business model is to achieve a sustainable compound annual growth rate (CAGR) of 5-7% at constant currency through 2030, a target that requires the successful commercial scaling of the Medicare Advantage portfolio and the continuous expansion of the specialty care network. This pivot has resulted in a highly diversified portfolio where growth is now being driven by the rapid scaling of next-generation assets, including the Magellan Health behavioral health network and the Medicare Advantage portfolio. The clinical logistics market is particularly vicious because manufacturer switching costs are high, and biotech companies are reluctant to change logistics providers unless new data demonstrates superior product integrity and a faster time-to-clinic. This dynamic creates a constant tension between internal operational productivity and external capital deployment, a balance that the executive leadership team has managed by strictly prioritizing acquisitions that offer late-stage, de-risked assets in areas where Centene already has operational scale. While the growth rate of the core Medicaid segment has begun to normalize as it reaches saturation in the traditional government market, the combined sales of the Medicare Advantage portfolio and the specialty care services segment demonstrated that the company's next generation of assets is beginning to achieve commercial scale and offset the margin compression in the legacy business. The FY2024 financial performance validates the strategic decision to pivot aggressively toward specialty and logistics assets, as the addition of Magellan Health and the expansion of the Medicare Advantage portfolio have significantly improved the company's overall revenue diversification and reduced its exposure to the highly competitive Medicaid distribution market. The US market remains the most profitable region, contributing approximately 100% of total revenue but an even higher percentage of operating profit due to the significantly higher volumes and operational scale in the United States compared to international markets. This specific operational architecture is protected by a dense thicket of regulatory approvals, state contracts, and proprietary analytics software that do not expire, creating a barrier to entry that is virtually impossible to close quickly. The clinical data and risk adjustment visibility package surrounding Centene's operations, encompassing billions of data points on member use, diagnosis codes, and social determinants of health across the entire US healthcare system, represents a competitive advantage that is rooted in deep operational expertise, massive capital barriers, and regulatory exclusivity. The transition to behavioral health integration with Magellan Health further solidifies this competitive advantage. The manufacturing and logistics moat for the company's specialty products is equally formidable. Centene operates specialized, state-of-the-art care management facilities designed to handle the complex biological processes required to store and transport cell and gene therapies at commercial scale, equipped with proprietary cryogenic storage technologies and specialized clean rooms that minimize contamination risks and ensure the consistent, high-yield delivery of the final drug product. The sheer cost and regulatory complexity of building and operating these facilities deter all but the most well-capitalized competitors from attempting to enter the specialty logistics space, giving Centene a significant cost and scale advantage that will be difficult to replicate. This regulatory expertise, combined with its logistics scale and operational data dominance, creates a comprehensive competitive advantage that positions Centene as the undisputed leader in the rapidly evolving field of pharmaceutical supply chain management. The commercial infrastructure required to support this advantage is equally specialized. To fund these initiatives, the company maintains a disciplined capital allocation framework that prioritizes debt reduction, targeted acquisitions, and shareholder returns over large-scale, transformational mergers. Centene Corporation's strategic bet for the next three years is the complete domination of the integrated behavioral health market and the successful expansion of its Medicare Advantage footprint to capture the highest-margin segments of the senior healthcare market. Concurrently, the company is advancing the integration of its Medicare Advantage plans into a unified, national senior care network, a modality that could address a much broader patient population than the current fragmented Medicare landscape. In the biotech commercialization space, the expansion of the Healthcare Solutions GPO and consulting portfolio is expected to drive significant revenue growth in emerging markets, therapeutic areas where Centene now holds a first-mover advantage with its proprietary data analytics and supply chain optimization tools. The early data has shown promising improvements in therapy adherence and patient outcomes, suggesting that Centene could potentially launch these advanced specialty services by 2027, establishing another first-mover advantage in a completely new therapeutic area and creating a multi-billion dollar revenue stream that would significantly diversify the company's portfolio. Centene has established a dedicated data science hub in St. Louis, which is focused on developing machine learning algorithms to analyze large-scale administrative datasets, identify novel care bottlenecks, and optimize the design of the national provider network. The subsequent development of the specialty pharmacy model, which included the acquisition of Magellan Health in 2022 and the launch of various Medicare Advantage plans, generated tens of billions of dollars in cumulative revenue, transforming Centene from a traditional Medicaid administrator into a diversified healthcare services platform.

Palo Alto Networks, Inc. competitive advantage: Palo Alto Networks, Inc. Processed exactly 145 trillion security events across its global cloud infrastructure during fiscal year 2024, a massive telemetry engine that powers its Precision AI platform and establishes an insurmountable data advantage in the cybersecurity sector. The economic engine of the company under CEO Nikesh Arora relies on a platformization strategy that explicitly targets the consolidation of the fragmented cybersecurity market; rather than selling isolated point solutions for endpoint, cloud, network, and security operations, Palo Alto Networks offers a unified platform that allows customers to retire an average of eight competing security products and reduce their vendor count by eleven, a value proposition that dramatically lowers total cost of ownership and creates immense switching costs. The customer acquisition cost (CAC) for Palo Alto Networks is heavily subsidized by its massive global channel partner ecosystem, which comprises over 11,000 partners, including global system integrators, value-added resellers, and managed security service providers. The subscription model also benefits from high switching costs; once the Palo Alto Networks firewall is deployed at the network perimeter, and the Prisma Cloud suite is integrated with the customer's AWS, Azure, and GCP environments, ripping out the platform requires a multi-month remediation project and introduces significant operational risk, creating a structural lock-in that results in industry-leading retention metrics. The economic moat is widened by the data network effect inherent in the platformization model; every new customer that deploys the firewall or cloud security agent contributes unique telemetry to the global protect infrastructure, which is immediately used to retrain the Precision AI models and improve detection accuracy for all existing customers, creating a virtuous cycle where the product becomes exponentially more effective as the customer base grows. The overall business model is a masterclass in enterprise platform consolidation: acquire the customer through a high-performance network firewall, expand revenue through frictionless software module toggles and cloud security attachments, retain the customer through high switching costs and data network effects, and defend the margin through channel-led distribution and cloud infrastructure scalability. The company's competitive moat is anchored by the massive scale of its telemetry engine, the architectural superiority of its network and cloud security capabilities, and the elite threat intelligence of the Unit 42 research team. CrowdStrike's advantage lies in its pure-play cloud-native heritage and its dominant mindshare among CISOs for endpoint and identity security, while Palo Alto Networks' advantage lies in its unrivaled network visibility, its comprehensive cloud security posture management (CSPM) capabilities, and its ability to correlate network traffic with cloud configurations in a way that endpoint-centric vendors cannot. Palo Alto Networks' competitive advantage lies in its ability to prove superior platform breadth and integration depth, offering customers a single vendor that can secure the network perimeter, the multi-cloud environment, the remote workforce, and the security operations center with a unified data model and a single management console, a value proposition that resonates powerfully with enterprise IT teams drowning in alert fatigue and vendor sprawl. The competitive moat is also defended through the channel partner ecosystem; Palo Alto Networks' 11,000 partners are incentivized by higher margin structures and the financial attractiveness of selling large, multi-year platform consolidation deals, leading them to recommend the Palo Alto Networks platform over more complex, multi-vendor alternatives from Fortinet and Microsoft. CrowdStrike's advantage lies in its pure-play cloud-native heritage, which allows it to process endpoint telemetry with lower latency and higher fidelity than Palo Alto Networks, which must integrate endpoint data from its acquired XDR assets with its legacy network and cloud data streams, occasionally resulting in integration friction and data normalization challenges. Palo Alto Networks' unreplicable competitive moat is the sheer scale and architectural superiority of its network security and cloud security posture management (CSPM) capabilities, anchored by the proprietary App-ID, User-ID, and Content-ID engines that process and classify network traffic with a level of granularity that no endpoint-centric competitor can replicate. The second pillar of the competitive advantage is the global protect infrastructure, a massive, cloud-native telemetry engine that processes over 145 trillion security events daily from millions of firewalls, cloud workloads, and endpoints globally, creating a machine learning training dataset that is uniquely comprehensive in its coverage of network traffic patterns, cloud configuration drifts, and adversary command-and-control communications. The competitive moat is further fortified by the company's massive channel partner ecosystem, which comprises over 11,000 partners that are deeply trained and certified in the complexities of the platform, creating a self-reinforcing cycle where the partner community drives the majority of new business and provides the localized support required for large-scale enterprise deployments. The integration of Precision AI, a generative AI engine trained on the entirety of the 145 trillion daily security events, allows security analysts to query the platform using natural language, automatically triage alerts, and generate remediation scripts, reducing the required security operations center (SOC) headcount and shifting the value proposition from 'providing data' to 'providing automated outcomes.' The competitive moat is not merely technological but operational; Palo Alto Networks' ability to process 145 trillion events daily requires a cloud infrastructure architecture that is optimized for massive parallel processing and low-latency data retrieval, a technical hurdle that requires billions of dollars in cumulative R&D investment and a decade of iterative optimization, effectively barring new entrants from replicating the scale and efficacy of the platform. He realized that the internet had evolved from a network of simple file transfers and email into a complex ecosystem of dynamic web applications, encrypted traffic, and sophisticated evasion techniques, and that the only way to secure this new environment was to build a firewall that understood applications, users, and content, regardless of the port or protocol used. Zuk and his engineering team spent 16-hour days writing and rewriting the code, developing the proprietary App-ID, User-ID, and Content-ID engines that would become the foundation of the company's competitive advantage.

Future prospects matter as much as current results. The growth strategies below explain how Centene Corporation and Palo Alto Networks, Inc. each plan to expand from here.

Centene Corporation growth strategy: The introduction of the ACA Marketplace in 2014, and the subsequent expansion of Medicaid under the Affordable Care Act, triggered a model shift in the company's growth trajectory, transforming it from a regional operator into a national infrastructure provider for public health. The market has rewarded this diversification strategy with a stabilized equity valuation, recognizing that a company with a clear path to higher-margin revenue streams and a dominant position in the behavioral health supply chain is worth significantly more than the distressed, low-margin Medicaid administrator it was considered to be in the early 2000s. Headquartered in St. Louis, Missouri, and led by CEO Sarah London, the company employs approximately 73,000 people globally and focuses its capital allocation strategy on expanding its Medicaid, Medicare Advantage, and ACA Marketplace footprints, while integrating behavioral health services through its Magellan Health subsidiary. This segment relies on the continuous improvement of the company's state contracts, which are strategically located to ensure coverage in high-growth Medicaid expansion states. To mitigate the risks associated with the structural margin compression in the government-sponsored business, the business model incorporates aggressive inorganic growth and massive organic capital deployment. The company uses its substantial free cash flow to acquire specialty care providers and behavioral health networks that have already de-risked their lead assets through commercial launch. This bolt-on acquisition strategy is designed to fill the revenue gaps left by margin compression in the Medicaid business without relying solely on internal organic growth. The irony is, this logistical constraint creates a massive barrier to entry for competitors, as it requires the establishment of a decentralized network of specialized providers and validated care pathways, a capital-intensive infrastructure that Centene has spent the last decade building through the integration of Magellan Health and subsequent organic investments. For the administration of government-sponsored programs, the company has continuously invested in advanced tracking and monitoring systems to ensure compliance with CMS regulations, while also conducting rigorous audits of its provider networks to prevent fraud and abuse. The company has consistently returned over 50% of its free cash flow to shareholders through a progressive dividend policy and an aggressive share buyback program, a strategy that has supported the stock price during the transition period from the Medicaid-only era to the diversified healthcare services era. Centene Corporation generated $153.9 billion in FY2024 total revenue, operating as the largest provider of government-sponsored healthcare programs in the United States and a rapidly expanding global commercialization powerhouse that commands a 2.3% operating margin by focusing exclusively on high-volume, low-margin Medicaid administration and higher-margin specialty logistics. The company's strategic identity was defined through the 2022 acquisition of Magellan Health, a massive corporate shift that eliminated the legacy branding and permanently removed the stigma of the opioid litigation era to focus on the future of behavioral health and senior care. Centene's response has been to shift its commercial strategy toward demonstrating the operational value of its specialty network, specifically its ability to reduce the incidence of therapy abandonment and improve patient adherence, thereby appealing to biotechnology manufacturers and value-based care providers rather than traditional PBMs. Centene's competitive strategy in this space relies on continuous lifecycle management, expanding the indications for its logistics services into new therapeutic areas and developing next-generation cold-chain technologies with enhanced temperature monitoring and reduced transit times. The most significant competitive threat, however, comes from the rise of specialized biotechnology services companies that focus exclusively on single therapeutic areas or modalities. To counter this, Centene has adopted a 'buy and partner' strategy, using its massive balance sheet to acquire clinical-stage biotech services companies like World Courier and Healthcare Solutions, effectively outsourcing the early-stage discovery risk to the private markets and then using its global distribution infrastructure to maximize the value of the assets. Centene has responded by aggressively expanding its internal claims processing and audit management capabilities, specifically through the Healthcare Solutions segment, a strategy that could potentially eliminate the need for third-party 340B administrators and create a truly cost-competitive, vertically integrated compliance platform. Selling, general, and administrative expenses were tightly controlled, growing at a slower rate than revenue, which contributed to the margin expansion. This capital allocation strategy is designed to support the credit rating during the transition period from the Medicaid-only era to the diversified healthcare services era, signaling management's confidence in the long-term cash generation capabilities of the diversified healthcare services model. Any interruption in the supply of the specialized raw materials required for biologic manufacturing, or any delay in the customs clearance of clinical trial materials, would immediately halt the production and distribution of key therapies, resulting in lost revenue and potential damage to the company's reputation among biotechnology manufacturers who rely on consistent logistics for their product launches. The expansion of the redetermination process has created a complex web of churn and re-enrollment that has severely compressed the margins on drugs distributed to hospitals and alternate care sites, forcing Centene to invest heavily in specialized claims processing and audit management software to protect its already thin margins. Competitors like UnitedHealth Group and Elevance Health have attempted to replicate this scale, but they are locked in a mature, oligopolistic market where the marginal cost of building new state contracts exceeds the potential return on investment. The company's extensive experience in navigating the complex regulatory landscape for pharmaceutical distribution, which involves coordination between multiple government agencies including the FDA, the DEA, and various international customs authorities, provides it with a deep institutional knowledge base that accelerates the distribution and commercialization of new biotech assets. Centene has invested hundreds of millions of dollars in developing a dedicated commercial network that employs highly specialized supply chain consultants and biotech commercialization experts who manage the complex logistics of product launches, inventory management, and patient access. Centene Corporation's growth strategy is built on three specific, named initiatives with clear financial targets: the acceleration of the behavioral health franchise integration, the aggressive expansion of the Medicare Advantage portfolio through strategic acquisitions and internal operational improvement, and the systematic deleveraging of the balance sheet to maintain investment-grade credit status while servicing the opioid settlement. The company has committed to launching at least three new service offerings or major operational expansions between 2024 and 2030, a pipeline that includes potential growth drivers in integrated behavioral health, value-based senior care, and biotech commercialization consulting. The behavioral health franchise initiative is the foundation of this strategy, with the company investing heavily in operational integration and clinical infrastructure to expand the Magellan Health network into a unified, national platform. The Medicare Advantage growth strategy focuses on using the Centene brand to establish the company as the undisputed leader in senior care distribution. The company is advancing next-generation care management technologies and validated transportation routes for autologous cell therapies, as well as expanding the indication for its logistics services into new therapeutic areas and international markets. By continuously improving its credit profile, Centene can access lower-cost capital markets, reducing the cost of debt and freeing up additional cash flow for R&D investment and strategic acquisitions. The acquisition of Magellan Health and the partnership with various biotechnology companies demonstrate this approach, providing the company with de-risked, late-stage assets and critical operational capabilities that can be integrated into the existing commercial infrastructure to drive immediate revenue growth. The execution of this growth strategy requires a highly skilled and motivated workforce, and Centene has invested heavily in talent acquisition and development to ensure that it has the necessary scientific, logistical, and commercial expertise to succeed. Centene has also implemented a comprehensive training and development program for its employees, focusing on building the skills and capabilities required to succeed in the fast-changing healthcare services industry. The company's culture of operational excellence and collaboration is a key enabler of its growth strategy, building an environment where employees are encouraged to think creatively, take calculated risks, and work together to solve complex supply chain and commercialization challenges. The growth strategy also includes a strong focus on sustainability and corporate social responsibility, recognizing that the long-term success of the company is inextricably linked to the health and well-being of the communities in which it operates. Centene has committed to achieving net zero greenhouse gas emissions across its value chain by 2050, and has implemented a comprehensive environmental, social, and governance (ESG) program that focuses on reducing its environmental footprint, promoting diversity and inclusion, and ensuring access to healthcare for underserved populations, particularly in the global pharmaceutical supply chain. The company's ESG initiatives are integrated into its overall business strategy, and its performance against these goals is regularly monitored and reported to investor. The successful execution of Centene's growth strategy will require the company to navigate a complex and pattern external environment, characterized by rapid technological change, intense competition, and evolving regulatory and pricing pressures. However, the company's strong operational heritage, solid service portfolio, and disciplined capital allocation strategy provide a solid foundation for future growth, and its focus on new products and patient-centricity positions it well to deliver on its strategic objectives and create significant value for all investor. The company projects a 5-7% constant currency sales CAGR from 2024 to 2030, a growth rate that relies heavily on the successful commercial scaling of next-generation service offerings currently in development. The company's future outlook also includes a heavy reliance on artificial intelligence and machine learning to accelerate care management improvement and predict use signals for new biologic launches. Centene has partnered with leading AI companies to identify novel care bottlenecks and predict member adherence patterns, a strategy that could significantly reduce the cost of care and improve the commercial success rate of new biotech assets. In addition to specialty pharmacy, Centene is heavily invested in the development of next-generation global commercialization services, including regulatory consulting, market access strategy, and post-approval surveillance, modalities that have the potential to provide full-cycle commercialization solutions for biotechnology companies launching their first products. Surprisingly, the company's pipeline includes several internal programs developed through its research centers, as well as a solid portfolio of external assets acquired through strategic partnerships. Centene has invested heavily in its commercialization services facilities in Pennsylvania and Europe, and has established a dedicated commercial team to support the launch of these complex services. The company is also exploring the use of digital biomarkers and wearable devices to collect real-time patient data during specialty pharmacy engagements, which could provide more sensitive and objective measures of therapy adherence and accelerate the commercial success of new biologic assets. The successful implementation of these digital health initiatives has the potential to significantly improve the productivity of the company's operations organization and reduce the cost of care, ultimately leading to the faster and more efficient commercialization of new medicines. The company faces intense competition in all of its key service areas, and the failure of any of its next-generation service offerings could have a material adverse impact on its financial performance and growth trajectory. Despite these challenges, Centene's strong portfolio of healthcare services, solid operational infrastructure, and disciplined capital allocation strategy position it well to deliver sustained long-term growth and create significant value for its shareholders. This narrative of operational resilience, strategic reinvention, and financial discipline defines the modern Centene, an organization that has successfully used the massive cash flows from its legacy distribution business to rebuild its balance sheet while navigating the permanent reputational damage of its past.

Palo Alto Networks, Inc. growth strategy: This consolidation strategy is quantified by the company's '8-11-3' framework, which has driven a 95% gross retention rate and accelerated the adoption of its high-margin software suites, including Prisma Cloud for multi-cloud security and Cortex for security operations automation. Under CEO Nikesh Arora, the company has executed a relentless platformization strategy, acquiring over 15 companies to consolidate network, cloud, endpoint, and security operations into a single, unified platform driven by Precision AI. The core economic driver of the business model is the platformization strategy, a deliberate shift from selling best-of-breed point solutions to offering a comprehensive, unified security platform that consolidates network security, cloud security, endpoint security, and security operations into a single architecture. The land-and-expand strategy is quantified by the company's 95% gross retention rate and a net dollar retention rate that consistently exceeds 110%, meaning that for every $100 of annual recurring revenue acquired in a given year, that same cohort generates over $110 in the following year purely through upsells and cross-sells, independent of new customer acquisition. This expansion is driven by the smooth integration of acquired technologies into the core platform; for example, the acquisition of Bridgecrew (rebranded as Prisma Cloud Code Security) allowed the company to upsell existing network security customers into cloud security posture management (CSPM) and infrastructure-as-code scanning without requiring a new sales cycle or a new agent deployment. The company's operating leverage is further demonstrated by the divergence between revenue growth (14% total, 30% Next-Gen ARR) and operating expense growth, allowing non-GAAP operating margins to expand to 24% in FY2024. In the cloud security domain, Palo Alto Networks faces intense pressure from Wiz, a rapidly growing startup that has captured significant mindshare by offering an agentless, API-driven cloud security posture management (CSPM) solution that provides immediate visibility into cloud misconfigurations without requiring any deployment effort. The revenue concentration is well-diversified, with no single customer accounting for more than 2% of total revenue, and the geographic mix is expanding, with international revenue growing at 18% year-over-year, reducing the company's reliance on the mature North American market. The structural challenge of integrating over 15 distinct acquisitions into a single, unified platform cannot be overstated; each acquisition, from Bridgecrew to Dig to Talon, brings its own codebase, data model, and user interface, and the engineering effort required to normalize these disparate data streams into the single Pane of Glass experience promised by the platformization strategy is immense. Palo Alto Networks' growth strategy is explicitly defined by the 'Platformization' framework, a systematic initiative to capture specific market segments by deploying targeted modules that expand the customer's annual contract value without requiring a new sales cycle. The strategy is executed through the '8-11-3' consolidation framework, which quantifies the value proposition for enterprise customers: replacing eight security point solutions, consolidating eleven security vendors, and reducing three security operations centers, thereby lowering total cost of ownership by an average of 30% while improving security efficacy. This growth strategy is executed through a land-and-expand motion that relies on the existing customer base; rather than acquiring new customers, the sales team focuses on upselling the 45,000 existing subscription customers to adopt the full platform, a strategy that is significantly more capital efficient than new customer acquisition. The channel partner strategy is also evolving to support this framework; Palo Alto Networks is training its 11,000 partners to sell the platformization bundle as a comprehensive 'Security Transformation' package, offering partners a 20% margin uplift for deals that include three or more major platform modules, such as network security, cloud security, and security operations. The international growth strategy involves establishing regional headquarters in London, Frankfurt, and Singapore, and hiring 1,000 local sales and support personnel to penetrate the European and Asia-Pacific markets, where the adoption of platformization is accelerating due to the rapid digitization of legacy industries and the stringent regulatory requirements of the EU's NIS2 directive. The growth strategy also includes the development of industry-specific platform modules for healthcare, financial services, and critical infrastructure, which incorporate pre-built compliance templates and threat intelligence feeds tailored to the specific regulatory and adversary landscape of each vertical. The financial target of this growth strategy is to increase the average selling price (ASP) per customer from $120,000 to $200,000 by fiscal year 2027, a 66% increase that will be driven entirely by the platformization module attachment rate, without requiring a proportional increase in the sales headcount. The transition to consumption-based pricing for cloud security and security operations is also a critical component of the growth strategy, allowing customers to align their security spending with their actual usage, lowering the barrier to entry for the platform and accelerating the adoption of high-margin software modules. Palo Alto Networks' strategic bet for the next three years is the complete transformation of the enterprise security stack from a fragmented collection of point solutions into a single, AI-driven, unified platform, a transition anchored by the 'Platformization' strategy and the integration of Precision AI across all product lines. The introduction of Cortex XSIAM, the company's security operations platform, is the cornerstone of this strategy; XSIAM is a next-generation SIEM and SOAR platform capable of ingesting petabytes of security telemetry at a fraction of the cost of legacy SIEMs like Splunk, allowing Palo Alto Networks to displace incumbent log management vendors and consolidate security operations into a single, automated data lake. The international expansion strategy is a critical component of the future outlook, with the company targeting 35% of total revenue from international markets by fiscal year 2027, driven by the adoption of platformization in Europe and Asia-Pacific, where data sovereignty regulations require localized cloud infrastructure that Palo Alto Networks is actively building through regional data centers. The company's long-term financial model targets $10 billion in Next-Gen Security ARR by fiscal year 2027, a goal that requires maintaining a 25% compound annual growth rate (CAGR) while expanding non-GAAP operating margins to 40% through the operating leverage of the software platform. Zuk proposed a radical architectural shift to Check Point's leadership: abandon the legacy stateful inspection engine and build a completely new firewall from scratch that used deep packet inspection, application signature matching, and user identity integration. The team operated in stealth mode for two years, focusing entirely on building the core architecture of the next-generation firewall: a proprietary, single-pass software engine that could perform application identification, user identification, content scanning, and threat prevention in a single pass through the packet, eliminating the performance degradation that plagued multi-pass legacy firewalls.

A closer look at the financial trajectory of Centene Corporation and Palo Alto Networks, Inc. rounds out the comparison.

Centene Corporation: The administration of healthcare benefits for 26 million Americans, generating $153.9 billion in annual premium revenue, represents the physical manifestation of the United States government's reliance on private insurers to manage the complex logistics of public health programs. This structural constraint forces Centene to operate on thin operating margins, typically ranging from 2-4%, but generates massive absolute dollar profits due to the sheer scale of its $153.9 billion top line. The FY2024 financial results reveal a company in the midst of a high-wire act: navigating the complex regulatory landscape of Medicaid redeterminations, which have resulted in the disenrollment of millions of members, while simultaneously integrating the $15.3 billion acquisition of Magellan Health to expand its behavioral health and specialty care capabilities. This concentration of risk in the government-sponsored sector is being actively mitigated by the expansion of the specialty care portfolio, which generated over $20 billion in combined sales in FY2024. Centene Corporation is an American multinational managed care enterprise that reported $194.8B in FY2025 total revenue, operating as the largest provider of government-sponsored healthcare programs in the United States. Key revenue drivers include the Medicaid segment, which accounts for the vast majority of the $153.9 billion top line, and the rapidly growing Medicare Advantage and Specialty segments. Despite facing significant structural challenges, including the relentless margin compression caused by rising medical use rates and the political volatility of Medicaid redeterminations, Centene has maintained financial stability through the continuous improvement of its risk adjustment models and the strategic integration of Magellan Health, solidifying its position as a top-tier global healthcare services provider with a market capitalization of approximately $40 billion. Centene Corporation generates 100% of its $194.8B FY2025 revenue from the administration of government-sponsored healthcare programs, the sale of commercial insurance products, and the provision of specialty care services, a business model that relies entirely on regulatory compliance, complex risk adjustment algorithms, and the continuous improvement of medical loss ratios. The Medicaid segment is the undisputed core of the business, generating the vast majority of the $153.9 billion top line through the administration of managed care plans for low-income individuals, families, children, elderly, and people with disabilities. Honestly, the Medicare Advantage segment represents the second pillar of the business model, generating over $25 billion in FY2024 sales through the operation of Medicare Part C plans for seniors and disabled individuals. The Marketplace segment, operated through the ACA exchanges, represents the third pillar of the business model, generating over $15 billion in FY2024 sales. The Specialty segment, operated through Magellan Health and other subsidiaries, represents the fourth and fastest-growing pillar of the business model, generating over $20 billion in FY2024 sales. The $15.3 billion acquisition of Magellan Health in 2022 brought a network of owned and partnered behavioral health providers into the portfolio, while the acquisition of various Medicaid plans in new states secured exclusive distribution contracts for high-value government programs. With approximately 73,000 employees and a market capitalization of $40 billion, Centene allocates billions annually to operational improvement and strategic acquisitions, funding a pipeline of over 50 service expansions and enabling aggressive acquisitions in the specialty and logistics spaces. The company's future depends on its ability to execute a 5-7% constant currency sales CAGR through 2030, a target that requires the successful commercial launch of its behavioral health integration services and the continuous expansion of its dominant position in the US government-sponsored healthcare market to offset the impending margin compression of its core Medicaid business and the relentless financial pressure of the $6.4 billion opioid settlement. Centene Corporation reported $194.8B in total revenue for FY2025, representing a 12% increase compared to FY2023, driven by the continued solid commercial scaling of the Medicaid and Medicare Advantage portfolios and the expansion of its specialty care services network. The company's operating income surged to $3.5 billion, reflecting a highly efficient cost structure that delivered a 2.3% operating margin, figures that are characteristic of the high-volume, low-margin government-sponsored healthcare industry. Net income reached $2.2 billion, while free cash flow generation remained exceptionally strong at $4.0 billion, providing the financial flexibility to fund strategic acquisitions, service its debt obligations, and execute share repurchases. The balance sheet remains heavily used but structurally improving, with $12.5 billion in total long-term debt, allowing Centene to maintain a systematic debt reduction program while executing strategic acquisitions in the specialty care space. Net sales of $153.9 billion were composed of $110.0 billion from the Medicaid segment, $25.0 billion from the Medicare Advantage segment, $15.0 billion from the Marketplace segment, and $3.9 billion from the Specialty and other segments. The cost of goods sold (COGS) was $145.0 billion, resulting in a gross profit of $8.9 billion and a gross margin of 5.8%. Selling, general, and administrative (SG&A) expenses were $5.4 billion, or 3.5% of net sales, reflecting the significant operational investment required to maintain the national provider network and manage the complex regulatory landscape. The operating income of $3.5 billion was achieved after deducting amortization of intangible assets and other operating expenses, resulting in an operating margin of 2.3%. The net income of $2.2 billion was achieved after deducting income taxes and interest expense, resulting in an effective tax rate of 22.5%, which is slightly below the statutory US rate due to the favorable geographic mix of the company's profits and the use of various tax credits and incentives. The strong cash flow generation of $4.0 billion provided the company with the financial flexibility to return $2.0 billion to shareholders through dividends and share buybacks, while also funding $1.0 billion in strategic acquisitions and capital expenditures, and making the first annual payment of $400 million toward the opioid litigation settlement. The balance sheet at the end of FY2024 showed total assets of $75.0 billion, total liabilities of $62.5 billion, and total equity of $12.5 billion, resulting in a debt-to-equity ratio of 1.0, which is significantly improved from the 2000s peak but still reflects the highly used nature of the corporate structure. Centene has faced intense scrutiny from the DEA and state attorneys general regarding its compliance with the Controlled Substances Act, allegations that resulted in the aforementioned $6.4 billion settlement and ongoing monitoring requirements. The target is to achieve over $30 billion in annual behavioral health sales by 2030, a figure that would make this modality the company's second-largest revenue segment and significantly improve the overall operating margin profile. The goal is to achieve peak sales of over $40 billion for the Medicare Advantage portfolio by 2032, offsetting the inevitable margin compression of the legacy Medicaid business. The deleveraging strategy aims to reduce the company's total long-term debt from $12.5 billion to under $10 billion by 2028, using the solid free cash flow generated by the US distribution operations to systematically retire high-yield bonds and reduce the annual interest expense, while simultaneously making the required $400 million annual payments toward the opioid litigation settlement. The most critical component of this outlook is the national rollout of Magellan Health's integrated behavioral health solutions, a move that could potentially capture a significant share of the $50 billion annual behavioral health market and establish a new standard of care for Medicaid and Medicare members seeking mental health and substance abuse treatment. However, this optimistic outlook is contingent on the successful navigation of several key risks, including the potential for regulatory changes to the Medicaid program, increased margin compression from retail pharmacy consolidation, and the continued financial burden of the $6.4 billion opioid litigation settlement.

Palo Alto Networks, Inc.: The financial manifestation of this strategic pivot is a Next-Gen Security Annual Recurring Revenue (ARR) figure of $4.24 billion, which grew 30% year-over-year and now represents the core economic engine of the enterprise, driving a blended gross margin of 76.7% and generating $2.5 billion in free cash flow. The company's trajectory from a stealth-mode startup in 2005 to a $118 billion market capitalization enterprise software giant is defined by a singular architectural realization by founder Nir Zuk: traditional stateful inspection firewalls, which only examined network ports and protocols, were fundamentally blind to the application-layer traffic that modern malware and advanced persistent threats used to bypass security controls. Headquartered in Santa Clara, California, Palo Alto Networks employs 16,000 personnel globally, commands a $118 billion market capitalization, and processes 145 trillion security events daily to train its machine learning models and deliver real-time threat prevention. The business model relies on an '8-11-3' consolidation framework, driving a 95% gross retention rate and generating $4.24 billion in Next-Gen Security ARR, positioning the company to capture the majority of the $50 billion security platform consolidation market. Palo Alto Networks generates its revenue through a hybrid model that is rapidly shifting from legacy hardware sales to high-margin software subscriptions, with Next-Gen Security Annual Recurring Revenue (ARR) reaching $4.24 billion in fiscal year 2024, representing a 30% year-over-year increase and accounting for the vast majority of the company's growth trajectory. The system sales segment, which historically drove the company's early growth, is now in structural decline as customers migrate to virtualized firewalls (VM-Series) and cloud-native firewall as a service (FWaaS) offerings; however, it still generates approximately $1.5 billion annually and serves as the critical hardware wedge for attaching high-margin software subscriptions. The software and subscription segments are the core economic drivers, generating over $5.4 billion in revenue with gross margins exceeding 80%, driven by the scalability of the cloud infrastructure and the zero marginal cost of replicating software code. The gross margin profile of the business is heavily skewed by the software and subscription streams, which maintain an 80%+ gross margin due to the cloud infrastructure costs and the scalability of the Precision AI engine, which processes 145 trillion events daily without requiring proportional increases in compute spend. In contrast, the hardware system sales segment carries a gross margin of approximately 55%, as it involves the physical manufacturing, supply chain logistics, and shipping of physical appliances, though the company intentionally prices the hardware aggressively to drive the attachment of the high-margin software subscriptions. The financial efficiency of this model is evident in the free cash flow generation, which reached $2.5 billion in fiscal year 2024, representing a free cash flow margin of approximately 36%, demonstrating the cash-generative power of the subscription model and the company's ability to fund its aggressive M&A strategy entirely through operating cash flows. Palo Alto Networks, Inc. Processed 145 trillion security events daily through its global protect infrastructure in fiscal year 2024, generating $6.95 billion in total revenue with a 36% free cash flow margin and achieving $4.24 billion in Next-Gen Security ARR, representing a 30% year-over-year increase. Headquartered in Santa Clara, California, Palo Alto Networks employs 16,000 personnel globally, commands a $118 billion market capitalization, and maintains a dominant position in network security and cloud security posture management. Despite facing acute challenges from CrowdStrike in security operations and Fortinet in network price-performance, Palo Alto Networks' strategic pivot toward AI-driven platform consolidation positions it to capture the next $50 billion expansion in the total addressable market. The global cybersecurity market is a fiercely contested $200 billion arena, and Palo Alto Networks occupies the dominant position in the network security and cloud security segments, generating $6.95 billion in annual revenue, while competing directly with CrowdStrike in security operations, Fortinet in network security, and Microsoft in endpoint and identity protection. Palo Alto Networks generated exactly $6.95 billion in total revenue for fiscal year 2024 (ended July 31, 2024), representing a 14% year-over-year increase from $6.09 billion in fiscal year 2023, driven by a massive 30% surge in Next-Gen Security Annual Recurring Revenue (ARR) to $4.24 billion, which now represents the core growth engine of the enterprise. The company's total subscription and software revenue grew 22% year-over-year to $4.84 billion, reflecting the successful execution of the platformization strategy and the rapid adoption of the Prisma Cloud, Cortex, and Cloud-Delivered Security Services (CDSS) portfolios. Gross profit for FY2024 was $5.33 billion, yielding a gross margin of 76.7%, a slight decline from 77.5% in FY2023 due to the continued mix shift toward lower-margin hardware sales in the early part of the year and the increased proportion of professional services, though the pure software and subscription gross margin remained exceptionally strong at over 80%. Operating income on a GAAP basis was $1.16 billion, representing a 16.7% operating margin, a significant improvement from $834 million in FY2023, driven by the operating leverage of the software business and disciplined expense management. On a non-GAAP basis, which excludes $1.4 billion in stock-based compensation and $450 million in acquired intangible amortization, operating income was $2.74 billion, yielding a non-GAAP operating margin of 39.4%, an expansion of 200 basis points from 37.4% in FY2023, demonstrating the immense profitability of the platformization model at scale. Net income on a GAAP basis was $1.16 billion, or $0.74 per diluted share, compared to $834 million in FY2023, while non-GAAP net income was $2.74 billion, or $1.71 per diluted share, representing a 24% year-over-year increase and significantly beating Wall Street consensus estimates. Free cash flow generation was a standout metric, reaching $2.5 billion in FY2024, representing a free cash flow margin of 36%, an increase from $2.1 billion (34.5% margin) in FY2023, demonstrating the cash-generative power of the subscription model and the company's ability to fund its aggressive M&A strategy and share repurchase program entirely through operating cash flows. The balance sheet at the end of FY2024 was exceptionally strong, with $5.8 billion in cash, cash equivalents, and investments, and $3.5 billion in long-term debt, providing the company with the financial flexibility to pursue strategic acquisitions, such as the recent acquisitions of Dig, Talon, and Aperture, without diluting shareholders through excessive equity issuance. For fiscal year 2025, Palo Alto Networks guided for total revenue between $8.0 billion and $8.1 billion, representing 15% to 16% year-over-year growth, with Next-Gen Security ARR expected to grow at a constant currency rate of 25% to 26%, reflecting the continued momentum of the platformization strategy and the accelerating adoption of the Precision AI and Prisma Cloud suites. The financial trajectory is characterized by a deliberate shift from hardware-dependent growth to high-margin, software-driven profitability, with the company achieving the 'Rule of 40' (revenue growth rate plus free cash flow margin = 50%) significantly outperforming the benchmark, a metric that institutional investors use to identify high-quality enterprise software businesses. The primary financial risk is the $1.4 billion annual stock-based compensation expense, which dilutes shareholders by approximately 2.0% annually, a figure that is unlikely to decrease in the near term given the highly competitive market for elite software engineering and AI talent and the necessity to retain the executive leadership team. CrowdStrike's cloud-native endpoint detection and response (EDR) architecture, combined with its LogScale SIEM and Charlotte AI generative assistant, directly competes with Palo Alto Networks' Cortex XSIAM and Cortex XDR offerings, creating a fierce battle for the $15 billion security operations market share. The company is aggressively expanding its total addressable market (TAM) from the $15 billion network security segment to the $50 billion broader security platform market by capturing workloads in cloud security, endpoint security, security operations, and identity protection. The future outlook relies on the premise that the modern enterprise security operations center (SOC) is drowning in alert fatigue, processing an average of 11,000 security alerts per day, of which 99% are false positives; Palo Alto Networks' solution is to use Precision AI to autonomously triage, investigate, and remediate these alerts, reducing the required SOC headcount by 50% and shifting the value proposition from 'detecting threats' to 'automating security operations.' The company is also betting heavily on cloud security, recognizing that 85% of enterprises are now multi-cloud, and the Prisma Cloud suite is positioned to become the default security layer for AWS, Azure, and GCP environments, capturing the $8 billion cloud security posture management (CSPM) and cloud workload protection (CWPP) market currently fragmented among Wiz, Orca, and Lacework. However, the structural shift toward AI-driven, platform-based security operations is irreversible, and Palo Alto Networks' first-mover advantage in network security and cloud security positions it to capture the majority of the $50 billion expansion in security platform spending over the next decade. He founded Palo Alto Networks in 2005 with $5 million in seed funding from Sequoia Capital, assembling a team of elite network engineers who had previously worked on high-throughput routing and switching technologies at Cisco and Juniper.